734 related articles for article (PubMed ID: 8384448)
1. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
2. Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit platelets.
Packham MA; Ruben DH; Rand ML
J Lipid Mediat Cell Signal; 1996 Dec; 15(1):69-87. PubMed ID: 9029375
[TBL] [Abstract][Full Text] [Related]
3. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.
Nunn DL; Watson SP
Biochem J; 1987 May; 243(3):809-13. PubMed ID: 2821994
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretion.
Joseph S; Krishnamurthi S; Kakkar VV
Biochim Biophys Acta; 1988 Apr; 969(1):9-17. PubMed ID: 2832002
[TBL] [Abstract][Full Text] [Related]
5. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
6. The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin.
Watson SP; McNally J; Shipman LJ; Godfrey PP
Biochem J; 1988 Jan; 249(2):345-50. PubMed ID: 3257691
[TBL] [Abstract][Full Text] [Related]
7. A role of diacylglycerol kinase in stimulus-secretion coupling of human platelets. Dissociation of serotonin secretion from Ca2+ mobilization.
Tohmatsu T; Nakashima S; Hattori H; Suganuma A; Nozawa Y
Thromb Res; 1987 Jul; 47(1):25-35. PubMed ID: 2821648
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets.
Iorio P; Gresele P; Stasi M; Nucciarelli F; Vezza R; Nenci GG; Goracci G
FEBS Lett; 1996 Mar; 381(3):244-8. PubMed ID: 8601464
[TBL] [Abstract][Full Text] [Related]
9. The diacylglycerol kinase inhibitor, R59022, potentiates cholecystokinin-induced enzyme secretion from rabbit pancreatic acini.
Ederveen AG; van Emst-de Vries SE; De Pont JJ; Willems PH
Eur J Biochem; 1990 Mar; 188(2):333-8. PubMed ID: 1690650
[TBL] [Abstract][Full Text] [Related]
10. 1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type.
Krishnamurthi S; Joseph S; Kakkar VV
Eur J Biochem; 1987 Sep; 167(3):585-93. PubMed ID: 3653105
[TBL] [Abstract][Full Text] [Related]
11. Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C.
Walker TR; Watson SP
Br J Pharmacol; 1992 Mar; 105(3):627-31. PubMed ID: 1628149
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of arachidonic acid mobilization in human platelets by R59 022, a diacylglycerol kinase inhibitor.
Mahadevappa VG; Sicilia FJ
Biochim Biophys Acta; 1988 Aug; 961(3):309-15. PubMed ID: 2840967
[TBL] [Abstract][Full Text] [Related]
13. R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet.
de Chaffoy de Courcelles DC; Roevens P; Van Belle H
J Biol Chem; 1985 Dec; 260(29):15762-70. PubMed ID: 2999135
[TBL] [Abstract][Full Text] [Related]
14. Inositol phospholipid metabolism in human platelets stimulated by ADP.
Vickers JD; Kinlough-Rathbone RL; Packham MA; Mustard JF
Eur J Biochem; 1990 Oct; 193(2):521-8. PubMed ID: 2171937
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
16. Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors.
Bishop WR; August J; Petrin JM; Pai JK
Biochem J; 1990 Jul; 269(2):465-73. PubMed ID: 2386487
[TBL] [Abstract][Full Text] [Related]
17. The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: comparison with thrombin.
Si-Tahar M; Renesto P; Falet H; Rendu F; Chignard M
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):401-8. PubMed ID: 8573071
[TBL] [Abstract][Full Text] [Related]
18. Daphnoretin, a new protein kinase C activator isolated from Wikstroemia indica C.A. Mey.
Ko FN; Chang YL; Kuo YH; Lin YL; Teng CM
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):321-7. PubMed ID: 8216237
[TBL] [Abstract][Full Text] [Related]
19. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
[TBL] [Abstract][Full Text] [Related]
20. Induction of the fibrinogen receptor on human platelets by intracellular mediators.
Shattil SJ; Brass LF
J Biol Chem; 1987 Jan; 262(3):992-1000. PubMed ID: 3100533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
